Intravenous ferric carboxymaltose for anaemia in pregnancy
Keywords:Iron deficiency anaemia, Ferric carboxymaltose, Haemoglobin
Background: Anaemia in pregnancy is associated with unfavourable consequences both for the mother and the fetus and is a major cause of maternal and perinatal mortality and morbidity.
Methods: The study was conducted over a period of one year in which 100 pregnant females who met the inclusion criteria were administered ferric carboxymaltose (FCM) preparation.
Results: There was significant rise in mean haemoglobin and serum ferritin after transfusion of ferric maltose in the patients with very less adverse effects.
Conclusions: FCM, because of its high efficacy and safety can revolutionize the management of iron deficiency anaemia (IDA) in pregnancy.
World Health Organisation. Micronutrient deficiencies: prevention and control guidelines. Geneva: World Health Organization. 2015. Available at https://www.who.int/nutrition/topics/ ida/en/. Accessed on 2 December 2018.
Lone FW, Qureshi RN, Emmanuel F. Maternal anaemia and its impact on perinatal outcome in a tertiary care hospital in Pakistan. East Mediterr Health J. 2004;10(6):801-7
Gautam CS, Saha L, Sekhri K, Saha PK. Iron deficiency in pregnancy and the rationality of iron supplements prescribed during pregnancy. Medscape J Med. 2008;10(12):283.
Bodnar LM, Cogswell ME, McDonald T. Have we forgotten the significance of postpartum iron deficiency? Am J Obstet Gynecol. 2005;193(1): 36-44.
Ehrenthal DB, Chichester ML, Cole OS, Jiang X. Maternal risk factors for peripartum transfusion. J Womens Health. 2012;21(7):792-7.
Ann Hematol. Postpartum anaemia II: Prevention and treatment. 2012;91(2):143-54.
Centre for disease control (CDC), criteria for anaemia in children and child bearing age women MMWR. 1989;38:400-4; Available at; https://www. cdc.gov/MMWR/preview/mmwrhtml/00051880.htmAccessed on 20 November 2018.
Indian council of medical research evaluation of nutritional anaemia prophylaxis program task force study New Delhi; 1989. Available at; https://www.icmr.nic.in/sites/default/files/icmr_bulle tins/bufeb00.pdf. Accessed on 12 December 2018.
FOGSI General Clinical Practice Recommenda- tions. Management of Iron Deficiency Anaemia in Pregnancy. Available at; www.fogsi.org/wpcontent/ uploads/2017/07/gcpr-recommendationida.pdf. Accessed on 16 January 2018.
Roberts CL, Ford JB, Thompson JF, Morris JM. Population rates of haemorrhage and transfusions among obstetric patients in NSW: a short communication. Aust N Z J Obstet Gynaecol. 2009;49(3):296-98.
Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med. 2010;268(3):286-95.
Shander A, Javidroozi M, Perelman S, Puzio T, Lobel G. From bloodless surgery to patient blood management. Mt Sinai J Med. 2012;79(1):56-65.
Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anaemia: a randomized trial. J Matern Fetal Neonatal Med. 2013;26(7):654-9.
Chertow GM, Hsu CY, Johansen KL. The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol. 2006;17(6):1501-2.
Khalafallah AA, Dennis AE. Iron deficiency anaemia in pregnancy and postpartum: Pathophysiology and effect of oral versus intravenous iron therapy. J Pregnancy. 2012; 2012:10.
Milman N, Bergholt T, Byg KE, Eriksen L, Graudal N. Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand. 1999;78(9):749-57.
Joshi SD, Chikkagowdra S, Kumar VCM. Comparative study of efficacy and safety of intravenous ferric carboxy maltose versus iron sucrose in treatment of postpartum iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol. 2016;5.
Patel AR, Patel VS, Patel PR. A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anaemia during pregnancy. Int J Reprod Contracept Obstet Gynecol.;9(6):2438.